Ligand-dependent notch signaling in vascular formation

Advances in Experimental Medicine and Biology

Volumn 727, Issue , 2012, Pages 210-222

  Kume, Tsutomu ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA LIKE 1; DELTA LIKE 4; EPHRIN B2; FIBROBLAST GROWTH FACTOR 2; JAGGED1; JAGGED2; LIGAND; MEMBRANE PROTEIN; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; NOTCH4 RECEPTOR; PLATELET DERIVED GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; CALCIUM BINDING PROTEIN; DLK1 PROTEIN, MOUSE; DLL4 PROTEIN, HUMAN; DLL4 PROTEIN, MOUSE; SERRATE PROTEINS; SIGNAL PEPTIDE;

ANGIOGENESIS; ARTERIOVENOUS MALFORMATION; ARTICLE; CADASIL; CELL DIFFERENTIATION; CELL INTERACTION; CELL MATURATION; CELL SPECIFICITY; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HUMAN; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PERIPHERAL ISCHEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; ANIMAL; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

MAMMALIA;

ANIMALS; CALCIUM-BINDING PROTEINS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, NOTCH;

EID: 84859516498     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-0899-4_16     Document Type: Article

References (70)

1. Bray SJ. Notch signalling: A simple pathway becomes complex. Nat Rev Mol Cell Biol 2006; 7(9):678-689.
2. Ava JA, Truela-Arispe ML. Notch signaling in vascular morphogenesis. Curr Opin Hernatol 2004; 1 1(4):278-283.
3. Gridley T. Notch signaling invasculardevelopment andphysiology. Development2007; 134( 15):2709-271 8.
4. Hofriann JJ, Iruela-Arispe ML. Notch signaling in blood vessels: Who is talking to whom about what? Circ Res 2007; 100(11):1556-1568.
5. Phng LK, Gerhardt H. Angiogenesis: A team effort coordinated by notch. Dev Cell 2009; 16(2):196-208.
6. Roca C, Adams RH. Regulation of vascular morphogenesis by Notch signaling. Genes Dev. 15 2007;21(20):251 1-2524.
7. Talora C, Campese AF, Bellavia D et al. Notch signaling and diseases: An evolutionary journey from a simple beginning to complex outcomes. Biochim Biophys Acta 2008; 1782(9):489-497.
8. KomatsuH, Chao MY, Larkins-FordJet al. OSM-1 1 facilitates LIN-12 Notch signaling during Caenorhabditis elegans vulval development. PLoS Biol 2008; 6(8):e196.
9. Kopan R, Ilagan MX. The canonical Notch signaling pathway: Unfolding the activation mechanism. Cell 2009; 137(2):216-233.
10. Fiuza UM, Arias AM. Cell and molecular biology of Notch. J Endocrinol 2007; 194(3):459-474.
11. Zolkiewska A. ADAM proteases: Ligand processing and modulation of the Notch pathway. Cell Mol Life Sci 2008; 65(13):2056-2068.
12. D'SouzaB,MiyamotoA,WeinniasterG. ThemanyfacetsofNotch1igands. Oncogene2008; 27(38):5 148-5167.
13. Krebs LT, Xue Y, Norton CR et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev 2000; 14(11):1343-1352.
14. Wu J, Bresnick EH. Glucocorticoid and growth factor synergism requirement for Notch4 chromatin domain activation. Mol Cell Biol 2007; 27(6):2411-2422.
15. Wu J, Iwata F, Grass JA et al. Molecular determinants of NOTCH4 transcription in vascular endothelium. Mol Cell Biol 2005; 25(4):1458-1474.
16. Joutel A, Andreux F, Gaulis S et al. The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. J Clin Invest 2000; 105(5):597-605.
17. Wu J, Bresnick EH. Bare rudiments of notch signaling: How receptor levels are regulated. Trends Biochem Sci 2007; 32(10):477-485.
18. Beckers J, Clark A, Wunsch K et al. Expression of the mouse Deltal gene during organogenesis and fetal development. Mech Dev 1999; 84(1-2):165-168.
19. Sore nsen I, Adams RH, GosslerA. DLL 1-mediatedNotch activation regulates endothelial identity in mouse fetal arteries. Blood 2009; 1 13(22):5680-5688.
20. Villa N, Walker L, Lindsell CE et al. Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mech Dev 2001; 108(1-2):161-164.
21. Liu I-I, Kennard S, Lilly B. NOTCH3 expression is induced in mural cells through an autoregulatory loop that requires endothelial-expressed JAGGED1. Circ Res 2009; 104(4):466-475.
22. Hayashi H, Kume T. Foxc transcription factors directly regulate Dll4 and Hey2 expression by interacting with the VEGF-Notch signaling pathways in endothelial cells. PLoS ONE 2008; 3(6):e2401.
23. Hellstrom M, Phng LK, Hofriann JJ et al. Dll4 signalling through Notch1 regulates formation of tip cells during angiogenesis. Nature 2007; 445(7129):776-780.
24. Liu ZJ, Shirakawa T, Li Y et al. Regulation ofNotch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: Implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol 2003; 23(1):14-25.
25. Lobov TB, Renard RA, Papadopoulos Net al. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting. Proc Natl Acad Sci USA 2007; 104(9):3219-3224.
26. Patel NS, Li JL, Generali D et al. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res 2005; 65(19):8690-8697.
27. Seo S, Fujita H, Nakano Aet al. The forkheadtranscription factors, Foxc 1 and Foxc2, are required for arterial specification and lymphatic sprouting during vascular development. Dev Biol 2006; 294(2):458-470.
28. Williams CK, Li JL, Murga Met al. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function. Blood 2006; 107(3):93 1-939.
29. Lawson ND, Scheer N, Pham YN et al. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001; 128(19):3675-3683.
30. Lawson ND. Vogel AM. Weinstein BM. sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 2002; 3(1):127-136.
31. Limbourg FP, Takeshita K, Radtke F et al. Essential role of endothelial Notch 1 in angiogenesis. Circulation 2005; 111(14):1826-1832.
32. Takeshita K, Satoh M, Ti M et al. Critical role of endothelial Notch1 signaling in postnatal angiogenesis. Circ Res 2007; 100(1):70-78.
33. Uyttendaele H, Ho J, Rossant Jet al. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci USA 2001; 98(10):5643-5648.
34. Carlson TR, Yan Y, Wu X et al. Endothelial expression of constitutively active Notch4 elicits reversible arteriovenous malformations in adult mice. Proc Natl Acad Sci USA 2005; 102(28):9884-9889.
35. DuarteA, Hirashima M, Benedito Ret al. Dosage-sensitive requirement for mouse Dll4 in artery development. Genes Dev 2004; 18(20):2474-2478.
36. Gale NW, Dominguez MG, Noguera T et al. Haploinsufficiency of delta-like 4 ligand results in embryonic lethality due to major defects in arterial and vascular development. Proc Natl Acad Sci USA 2004; 10 1(45): 15949-15954.
37. Krebs LT, Shutter JR, Tanigaki K et al. Haploinsufficient lethality and formation of arteriovenous malformations in Notch pathway mutants. Genes Dev 2004; 18(20):2469-2473.
38. Limbourg A, Ploom M, Elligsen D et al. Notch ligand Delta-like 1 is essential for postnatal arteriogenesis. Circ Res 2007; 100(3):363-371.
39. Joutel A, Corpechot C, Ducros A et al. Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 1996; 383(6602):707-710.
40. Domenga V, Fardoux P, Lacombe P et al. Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. Genes Dev 2004; 18(22):2730-2735.
41. High FA, Lu MM, PearWS et al. Endothelial expression of the Notch ligand Jagged 1 is required for vascular smooth muscle development. Proc Natl Acad Sd USA 2008; 105(6): 1955-1959.
42. Robert-Moreno A, Guiu J, Ruiz-Herguido C et al. Tmpaired embryonic haematopoiesis yet normal arterial development in the absence of the Notch ligand Jaggedl. EMBO J 2008; 27(13):1886-1895.
43. Campos AH, Wang W, Pollman MJ et al. Determinants of Notch-3 receptor expression and signaling in vascular smooth muscle cells: Implications in cell-cycle regulation. Circ Res 2002; 91(11):999-1006.
44. Leslie JD, Ariza-McNaughton L, Bermange AL et al. Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis. Development 2007; 134(5):839-844.
45. Noguera-Troise I, Daly C, Papadopoulos NJ et al. Blockade of Dll4 inhibits tumour growth by promoting nonproductive angiogenesis. Nature 2006; 444(7122): 1032-1037.
46. Ridgway J, Zhang G, Wu Y et al. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis. Nature 2006; 444(7122): 1083-1087.
47. Samson RC, Aoto J, NakatsuMN et al. Cell-autonomous notch signaling regulates endothelial cell branching and proliferation during vascular tubulogenesis. FASEB J 2005; 19(8): 1027-1029.
48. Siekmann AF, Lawson ND. Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries. Nature 2007; 445(7129):781-784.
49. Suchting S, Freitas C, le Noble F et al. The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci USA 2007; 104(9):3225-3230.
50. Benedito R, Roca C, Sorensen I et al. The notch ligands Dll4 and Jaggedl have opposing effects on angiogenesis. Cell 2009; 137(6): 1124-1135.
51. Hainaud P, Confreres JO, Villemain A et al. The role of the vascular endothelial growth factor-Delta-like 4 ligand/Notch4-ephrin B2 cascade in tumor vessel remodeling and endothelial cell functions. Cancer Res 2006; 66(17):8501-8510.
52. Mailbos C, Modlich U, Lewis J et al. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis. Differentiation 2001; 69(2-3): 135-144.
53. ScehnetJS, Jiang W, Kumar SRet al. InhibitionofDll4-mediated signaling inducesproliferationofimmature vessels and results in poor tissue perfusion. Blood 2007; 109(11):4753-4760.
54. Li JL, Samson RC, Shi W et al. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function and promotes tumor growth in vivo. Cancer Res 2007; 67(23):1 1244-11253.
55. Thurston O, Noguera-Troise I, Yancopoulos GD. The Delta paradox: DLL4 blockade leads to more tumour vessels but less tumour growth. Nat Rev Cancer 2007; 7(5):327-331.
56. Zeng Q, Li S, Chepeha DB et al. Crosstalk betweentumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 2005; 8(1):13-23.
57. Dufraine J, Funahashi Y, Kitajewski J. Notch signaling regulates tumor angiogenesis by diversemechanisms. Oncogene 2008; 27(38):5132-5 137.
58. Funahashi Y, Hernandez SL, Das Jet al. A notch 1 ectodomain construct inhibits endothelial notch signaling, tumor growth and angiogenesis. Cancer Res 2008; 68(12):4727-4735.
59. Hirschi KK. Ingram DA. Yoder MC. Assessing identity, phenotype and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28(9): 1584-1595.
60. Kawamoto A, Losordo DW. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 2008; 18(1)33-37.
61. Prater DN, Case J, Ingram DA et al. Working hypothesis to redefine endothelial progenitor cells. Leukemia 2007; 21(6):1141-1149.
62. Kwon SM, Alev C, Asahara T. The role of notch signaling in endothelial progenitor cell biology. Trends Cardiovasc Med 2009; 19(5): 170-173.
63. KwonSM, Eguchi M,WadaMet al. Specific Jagged-1 signal from bone manow microenvironmentisrequired for endothelial progenitor cell development for neovascularization. Circulation 2008; 1 18(2):157-165.
64. JiM, Takeshita K, Ibusuki K et al. Notch Signaling Regulates Endothelial Progenitor Cell Activity During Recovery From Arterial Injury in Hypercholesterolemic Mice. Circulation 121(9): 1104-1112.
65. MiyamotoA, LauR, HeinPWet al. Microfibrillar proteins MAGP-1 and MAGP-2 induce Notch 1 extracellular domain dissociation and receptor activation. J Biol Chem 2006; 281(15):10089-10097.
66. Nehring LC, Miyarnoto A, Hem PW et al. The extracellular matrix protein MAGP-2 interach with Jagged! and induces its shedding from the cell surface. J Biol Chem 2005; 280(21):20349-20355.
67. Albig AR, Becenti DJ, Roy TO et al. Microfibril-associate glycoprotein-2 (MAGP-2) promotes angiogenic cell sprouting by blocking notch signaling in endothelial cells. Microvasc Res 2008; 76(1):7-14.
68. Albig AR, Roy TO, Becenti DJ et al. Transcriptome analysis of endothelial cell gene expression induced by growth on matrigel matrices: Identification and characterization of MAGP-2 and lumican as novel regulators of angiogenesis. Angiogenesis 2007; 10(3):197-216.
69. Hoey T, Yen WC, Axelrod F et al. DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell 2009; 5(2):168-177.
70. Kume T. Novel insights into the differential functions of Notch ligands in vascular formation. J Angiogenes Res 2009; 1:8.